Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intramuscular Injections – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intramuscular Injections – V 2.0

Standard Operating Procedure for Material Dispensing for IM Injection Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/002/2025
Supersedes SOP/SIM/002/2022
Page No. Page 1 of 13
Issue Date 17/06/2025
Effective Date 19/06/2025
Review Date 17/06/2026

1. Purpose

To define the standard procedure for dispensing raw materials required for the manufacturing of intramuscular (IM) injection formulations. This SOP ensures precision, traceability, and regulatory compliance under GMP, WHO,

and ICH guidelines.

2. Scope

This SOP applies to all dispensing operations related to the preparation of intramuscular injection formulations conducted at the Sterile Injectable Manufacturing facility.

3. Responsibilities

  • Warehouse Staff: Responsible for dispensing raw materials as per production requirements.
  • Production Chemist: Reviews requisition and receives dispensed materials.
  • QA Officer: Verifies dispensing records, ensures compliance, and authorizes material release.
  • QC Personnel: Confirms material quality through CoA verification and sampling.
See also  Sterile Injectable Manufacturing: SOP for Osmolality Testing of Injectable Products - V 2.0

4. Accountability

The Head of Sterile Injectable Manufacturing is accountable for the implementation, compliance, and periodic review of this SOP.

5. Procedure

5.1 Receiving Material Requisition

  1. Receive signed MRN from the Production department with material specifications, batch sizes, and required quantities.
  2. Check that MRN is authorized and complete.

5.2 Verification and Line Clearance

  1. Check material containers for intact packaging, labeling, and expiry status.
  2. Review CoA and cross-verify against batch number and specification.
  3. Ensure designated weighing area is cleaned and cleared (line clearance to be documented).

5.3 Material Weighing and Dispensing

  1. Carry materials into the classified weighing booth under RLAF after sanitizing outer surfaces.
  2. Use pre-cleaned containers and calibrated weighing balances with valid calibration status.
  3. Dispense each material accurately within ±0.1% of the specified weight.
  4. Document each weighing in the Material Dispensing Log (Annexure-1).
See also  Sterile Injectable Manufacturing: SOP for Automation System Checks in Injectable Filling Lines - V 2.0

5.4 Labeling and QA Verification

  1. Affix labels with details such as material name, quantity, batch number, date, and dispensed by.
  2. Present all containers and documentation for QA verification.
  3. QA to fill and sign the Approval and Release Form (Annexure-3).

5.5 Transfer and Documentation

  1. Transfer labeled and approved materials to the pre-cleanroom staging area.
  2. Ensure segregation of actives and excipients in transit.
  3. Ensure all dispensing documentation is signed and filed for traceability.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IM: Intramuscular
  • CoA: Certificate of Analysis
  • MRN: Material Requisition Note
  • QA: Quality Assurance
  • QC: Quality Control
  • RLAF: Reverse Laminar Air Flow

7. Documents

  1. Material Dispensing Log – Annexure-1
  2. Certificate of Analysis (CoA) – Annexure-2
  3. Approval and Release Form – Annexure-3

8. References

  • WHO GMP Guidelines – Annex 6: Manufacture of Sterile Medicinal Products
  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • Schedule M – Indian GMP Requirements
See also  Sterile Injectable Manufacturing: SOP for Handling Deviations in Manufacturing Stages - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Store Chemist QA Executive Head – Manufacturing
Department Warehouse Quality Assurance Sterile Injectable Manufacturing

11. Annexures

Annexure-1: Material Dispensing Log

Date Material Name Batch No. Qty Dispensed Dispensed By Checked By
17/06/2025 Benzyl Alcohol BN-IM125 250 mL Rajesh Kumar Sunita Reddy

Annexure-2: Certificate of Analysis (CoA)

Material Batch No. Test Specification Result Approved By
Benzyl Alcohol BN-IM125 Purity 98.0–102.0% 99.5% Ravi Sharma

Annexure-3: Approval and Release Form

Material Name Benzyl Alcohol
Batch No. BN-IM125
Qty Dispensed 250 mL
Date 17/06/2025
QA Approved By Sunita Reddy

Revision History

Revision Date Revision No. Details Reason Approved By
01/04/2022 1.0 Initial release New SOP QA Head
17/06/2025 2.0 Updated procedures and annexures Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Creams: SOP for Monitoring Batch Mixing Parameters in Cream Manufacturing – V 2.0
Next Post: API Manufacturing: SOP for Handling of Incidental Lab Spills – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version